Biofrontera Inc. Stock Issued During Period, Shares, New Issues
Biofrontera Inc. (BFRI) reported Stock Issued During Period, Shares, New Issues of 214.29 thousand shares for the 0-month period ending 2022-07-26, per its 10-K filed 2024-03-15.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-03-15
- 2022-07-26: Stock Issued During Period, Shares, New Issues 0 month 214.29K shares; Stock Issued During Period, Shares, New Issues 0 month as first filed 4.29M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 0 month as first filed |
|---|---|---|
| 2022-07-26 | 214.29K shares 10-K · filed 2024-03-15 | 4.29M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |